We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Contrast-enhanced ultrasound to predict malignant upgrading of atypical ductal hyperplasia.
- Authors
Li, Jun Kang; Jin, Zhi Ying; Xu, Yong Jie; Fu, Nai Qin; Jiang, Ying; Li, Shi Yu; Niu, Rui Lan; Liu, Gang; Wang, Zhi Li
- Abstract
Background: A malignancy might be found at surgery in cases of atypical ductal hyperplasia (ADH) diagnosed via US-guided core needle biopsy (CNB). The objective of this study was to investigate the diagnostic performance of contrast-enhanced ultrasound (CEUS) in predicting ADH diagnosed by US-guided CNB that was upgraded to malignancy after surgery. Methods: In this retrospective study, 110 CNB-diagnosed ADH lesions in 109 consecutive women who underwent US, CEUS, and surgery between June 2018 and June 2023 were included. CEUS was incorporated into US BI-RADS and yielded a CEUS-adjusted BI-RADS. The diagnostic performance of US BI-RADS and CEUS-adjusted BI-RADS for ADH were analyzed and compared. Results: The mean age of the 109 women was 49.7 years ± 11.6 (SD). The upgrade rate of ADH at CNB was 48.2% (53 of 110). The sensitivity, specificity, positive predictive value, and negative predictive value of CEUS for identification of malignant upgrading were 96.2%, 66.7%,72.9%, and 95.0%, respectively, based on BI-RADS category 4B threshold. The two false-negative cases were low-grade ductal carcinoma in situ. Compared with the US, CEUS-adjusted BI-RADS had better specificity for lesions smaller than 2 cm (76.7% vs. 96.7%, P = 0.031). After CEUS, 16 (10 malignant and 6 nonmalignant) of the 45 original US BI-RADS category 4A lesions were up-classified to BI-RADS 4B, and 3 (1 malignant and 2 nonmalignant) of the 41 original US BI-RADS category 4B lesions were down-classified to BI-RADS 4A. Conclusions: CEUS is helpful in predicting malignant upgrading of ADH, especially for lesions smaller than 2 cm and those classified as BI-RADS 4A and 4B on ultrasound.
- Subjects
CONTRAST-enhanced ultrasound; CORE needle biopsy; HYPERPLASIA; DUCTAL carcinoma; CARCINOMA in situ; CONTRAST media; ENDOMETRIAL hyperplasia
- Publication
Breast Cancer Research, 2024, Vol 26, Issue 1, p1
- ISSN
1465-5411
- Publication type
Article
- DOI
10.1186/s13058-024-01772-2